V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10470847 | 10065333 | null | null | null | 2017-11-14 | 2017-11-21 | BLEOMYCIN | N | null | CARFILZOMIB | 100737037 |
| 10470868 | 10065334 | null | null | null | 2019-10-16 | 2021-07-30 | IDELALISIB | 02 | null | SUNITINIB | 100394845 |
| 10470896 | 10065336 | 1.71 | 73.8 | Curative (C) | 2021-04-24 | 2021-04-24 | ANAGRELIDE | 02 | N | IFOSFAMIDE + GEMCITABINE + VINORELBINE + RITUXIMAB | 101400672 |
| 10471432 | 10065340 | 1.77 | 82.2 | Neo-adjuvant (N) | 2019-10-28 | 2019-10-31 | IDELALISIB + RITUXIMAB | N | N | TRIAL | 101558510 |
| 10471549 | 10065341 | 1.66 | 70.8 | Palliative (P) | 2017-01-01 | 2017-01-01 | AZACITIDINE + VENETOCLAX | null | N | TRANSPLANT CAR-T CELLS – BREXUCABTAGENE AUTOLEUCEL (KTE-X19) + CYCLOPHOSPHAMIDE + FLUDARABINE | 100835598 |
| 10472185 | 10065343 | 1.7 | 66.7 | Palliative (P) | 2016-11-24 | 2017-03-20 | REGORAFENIB | 02 | N | FULVESTRANT + RIBOCICLIB | 101530962 |
| 10472643 | 10065345 | 1.73 | 60.2 | null | 2020-11-23 | 2020-12-08 | Liposomal Doxorubicin 40mg/m2 | 02 | null | OBINUTUZUMAB + VENETOCLAX | 100471881 |
| 10472673 | 10065346 | 1.61 | 82.1 | Palliative (P) | 2020-07-29 | 2020-09-22 | Bendamustine +/- Prednisolone | 02 | N | TRASTUZUMAB EMTANSINE | 101243986 |
| 10472697 | 10065347 | 1.55 | 72.7 | Palliative (P) | 2020-04-11 | 2020-09-13 | CHLORAMBUCIL + RITUXIMAB | 99 | Y | MPV | 100903333 |
| 10472919 | 10065348 | 1.86 | null | null | 2017-08-04 | 2018-03-01 | ISATUXIMAB + POMALIDOMIDE | null | null | MPV | 100849447 |
| 10473367 | 10065349 | 1.88 | 75 | null | 2018-01-22 | 2018-01-22 | Gemcitabine + Capecitabine | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101429359 |
| 10473521 | 10065350 | 1.57 | 66 | Not known (9) | 2020-06-21 | 2021-03-06 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | N | AXITINIB | 101482861 |
| 10473777 | 10065352 | 1.77 | 78 | Palliative (P) | 2021-12-26 | 2021-12-27 | LENALIDOMIDE + RITUXIMAB | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101465874 |
| 10473818 | 10065353 | null | null | null | 2019-10-06 | 2019-10-06 | Pemetrexed | 02 | null | CISPLATIN + FLUOROURACIL | 101654071 |
| 10473954 | 10065354 | 1.75 | 0 | Palliative (P) | 2018-12-03 | 2018-12-14 | FLUOROURACIL + MITOMYCIN | 02 | N | AZACITIDINE + VENETOCLAX | 100472531 |
| 10474443 | 10065357 | 1.67 | 78.4 | Palliative (P) | 2018-07-11 | 2018-08-28 | ATG + Busulfan + Fludarabine | 02 | N | CYTARABINE | 100039506 |
| 10474469 | 10065358 | 1.84 | 40.3 | Palliative (P) | 2021-02-22 | 2021-02-28 | MaxiCHOP (>Cycle 2) | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100592980 |
| 10474518 | 10065359 | 1.54 | 0 | null | 2017-02-02 | 2019-05-19 | null | 02 | N | BCG | 100491764 |
| 10474622 | 10065360 | 1.59 | 81.2 | Palliative (P) | 2018-08-23 | 2018-10-11 | ANAGRELIDE | N | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101012081 |
| 10474890 | 10065363 | 1.65 | 54.4 | Palliative (P) | 2022-04-08 | 2022-04-08 | Irinotecan + Raltitrexed | null | N | MELPHALAN + THALIDOMIDE | 101623311 |
| 10475662 | 10065367 | 1.72 | 99 | Curative (C) | 2019-11-02 | 2019-11-02 | Ipilimumab | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100322867 |
| 10476503 | 10065370 | 1.64 | 89 | Curative (C) | null | 2021-06-28 | Docetaxel + Nintedanib | 02 | N | PACLITAXEL + TRASTUZUMAB | 100079048 |
| 10476546 | 10065371 | 1.94 | 0 | null | 2017-11-03 | 2017-11-07 | IDELALISIB + RITUXIMAB | null | null | NOT MATCHED | 101634362 |
| 10476699 | 10065372 | null | null | null | 2021-01-22 | 2021-04-05 | OCTOPUS Trial | 02 | null | STAMPEDE TRIAL | 101630583 |
| 10476731 | 10065373 | 1.51 | 89.4 | null | 2018-05-19 | 2018-05-19 | Paclitaxel albumin (Abraxane) 21day | 2 | null | OXALIPLATIN + MDG | 101747177 |
| 10476809 | 10065374 | 1.57 | 62.5 | null | 2021-09-22 | 2021-10-07 | EC | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100367528 |
| 10476822 | 10065375 | 1.55 | 40.9 | Palliative (P) | 2019-01-20 | 2019-02-11 | MITOMYCIN | 01 | N | UKALL60+ | 101273115 |
| 10477017 | 10065377 | 1.89 | 57.9 | null | 2020-04-10 | 2021-07-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 01 | null | OXALIPLATIN + MDG | 101585803 |
| 10477187 | 10065379 | 0 | 66.8 | null | 2017-09-15 | 2017-09-24 | null | N | null | UKALL60+ | 101650732 |
| 10477608 | 10065380 | 1.64 | 70 | null | 2019-07-19 | 2019-07-19 | null | null | null | TRABECTEDIN | 100258500 |
| 10477696 | 10065382 | 1.82 | null | Palliative (P) | 2021-06-26 | 2021-07-09 | Obinutuzumab +CVP | 02 | N | PEMETREXED | 101247612 |
| 10477850 | 10065383 | 0 | 75.2 | 03 | 2020-02-21 | 2020-06-05 | Irinotecan + Raltitrexed | 02 | N | GEMCITABINE + RITUXIMAB | 100777684 |
| 10477892 | 10065384 | 1.53 | 57.75 | Palliative (P) | 2020-01-06 | 2020-01-26 | ANAGRELIDE | 02 | N | FLUOROURACIL + MITOMYCIN | 101565779 |
| 10477994 | 10065385 | 1.52 | 66.7 | Palliative (P) | 2021-01-30 | 2021-02-01 | VISMODEGIB | N | N | MITOMYCIN INTRAVESICULAR | 101443972 |
| 10478176 | 10065388 | 1.84 | 68.7 | null | 2022-01-19 | 2022-02-08 | Busulfan Oral | N | null | LORLATINIB | 100836889 |
| 10478682 | 10065390 | 1.77 | 61 | Palliative (P) | 2019-03-06 | 2020-03-27 | Bendamustine +/- Prednisolone | N | N | CAR-T AXICABTAGENE CILOLEUCEL + CYCLOPHOSPHAMIDE + FLUDARABINE | 101181935 |
| 10478706 | 10065391 | 1.61 | 84.8 | Palliative (P) | null | 2019-07-15 | BENDAMUSTINE | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100376229 |
| 10478853 | 10065393 | 2.01 | 0 | null | null | 2019-12-31 | ROSCO Trial | N | null | CYTARABINE + DAUNORUBICIN | 101425103 |
| 10478938 | 10065394 | 1.88 | 0 | null | 2019-06-05 | 2019-06-11 | Cyclophosphamide Fludarabine (Oral) | 02 | null | CYTARABINE + DAUNORUBICIN | 100160650 |
| 10478975 | 10065395 | 1.61 | 72 | null | 2022-04-16 | 2022-04-19 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | null | FLUOROURACIL + MITOMYCIN | 100349456 |
| 10479050 | 10065396 | 1.55 | 101.6 | null | 2020-04-04 | 2020-04-04 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101216618 |
| 10479339 | 10065397 | 1.7 | 73.5 | null | null | 2018-08-11 | R Chlorambucil | 01 | null | GEFITINIB | 100786757 |
| 10479451 | 10065398 | 1.07 | 61.8 | Curative (C) | null | 2019-08-20 | EOX | 02 | N | EPIRUBICIN | 100627546 |
| 10479484 | 10065399 | 1.6 | 80.8 | Palliative (P) | 2020-11-24 | 2022-01-23 | Bexarotene | 02 | N | ERIBULIN | 101195190 |
| 10480204 | 10065400 | 1.66 | 78.5 | null | 2020-01-23 | 2020-01-23 | Capecitabine + Mitomycin | 02 | null | SUNITINIB | 101850637 |
| 10480458 | 10065403 | 1.92 | 47.8 | 03 | 2017-05-05 | 2018-06-01 | Mercaptopurine | 02 | N | BEVACIZUMAB | 101221005 |
| 10480650 | 10065405 | 1.81 | 44.9 | null | 2020-05-18 | 2020-06-08 | Dasatinib | 01 | null | CHOP | 101161113 |
| 10481070 | 10065408 | 1.82 | null | null | 2018-01-28 | 2018-02-11 | OSIMERTINIB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101718746 |
| 10481450 | 10065411 | 1.8 | 115 | null | 2022-04-13 | 2022-04-24 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | null | MELPHALAN + THALIDOMIDE | 100563695 |
| 10481585 | 10065412 | 1.68 | 80 | Curative (C) | 2016-08-02 | 2018-12-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN | 101268677 |